Skip to main content
. 2020 Dec 7;21(23):9333. doi: 10.3390/ijms21239333

Figure 1.

Figure 1

Interleukin-6 (IL-6) concentration (mean ± SEM) in the blood 24 h after pharmacological treatments. Statistically significant differences were detected between controls and PILO-treated and between pilocarpine(PILO)-treated and SZR104-treated animals (* p ≤ 0.05). SZR104-pretreated epileptic animals (SZR104 + PILO) displayed decreased IL-6 level, but the decrease was not statistically significant (blood IL-6 concentrations in pg/mL; blue dots display the number of measurements/blood samples).